Farther Finance Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9K | Buy |
16,236
+531
| +3% | +$913 | ﹤0.01% | 2459 |
|
|
2025
Q1 | $51K | Buy |
15,705
+66
| +0.4% | +$214 | ﹤0.01% | 1884 |
|
|
2024
Q4 | $116K | Buy |
15,639
+250
| +2% | +$1.85K | ﹤0.01% | 1240 |
|
|
2024
Q3 | $145K | Buy |
15,389
+9,037
| +142% | +$84.9K | 0.01% | 1138 |
|
|
2024
Q2 | $51.2K | Buy |
6,352
+255
| +4% | +$2.06K | ﹤0.01% | 1405 |
|
|
2024
Q1 | $86.5K | Buy |
6,097
+6,049
| +12,602% | +$85.8K | 0.01% | 988 |
|
|
2023
Q4 | $390 | Buy |
48
+11
| +30% | +$89 | ﹤0.01% | 3056 |
|
|
2023
Q3 | $168 | Hold |
37
| – | – | ﹤0.01% | 2486 |
|
|
2023
Q2 | $260 | Hold |
37
| – | – | ﹤0.01% | 2317 |
|
|
2023
Q1 | $226 | Buy |
+37
| New | +$226 | ﹤0.01% | 2182 |
|